Nycomed Amersham Imaging of Princeton, NJ, has extended its contrast agent supply relationships with group purchasing organizations VHA and University HealthSystem Consortium (UHC) to Novation, the new company formed to supply the GPOs. The extension
Nycomed Amersham Imaging of Princeton, NJ, has extended its contrast agent supply relationships with group purchasing organizations VHA and University HealthSystem Consortium (UHC) to Novation, the new company formed to supply the GPOs. The extension also incorporates new Nycomed contrast agents not covered in the previous deals, such as the companys Teslascan MRI liver imaging agent.
Nycomed Amersham previously had separate contrast supply deals with VHA of Irving, TX, and UHC of Oak Brook, IL. Those GPOs in January spun off their supply and purchasing organizations to form Novation, so Nycomed Amersham began negotiating a supply deal with the new entity.
The new agreement covers contrast agent purchasing for the next five years, beginning in January. It also includes provisions that should increase compliance among VHA and UHC members, according to a Nycomed Amersham spokesperson.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.